HomeBiotech

Biotech

Infectious Disease Research Through Unmet Needs Analysis, Pipeline Assessment, Disease Intelligence, Pricing Strategies, and Market Access Analysis by Disease Landscape Insights

Infectious Disease Research Through Unmet Needs Analysis, Pipeline Assessment, Disease Intelligence, Pricing Strategies, and Market Access Analysis by Disease Landscape Insights

September 26, 2023

WuXi Vaccines Launches Its First Vaccines CDMO Site in China

WuXi Vaccines Launches Its First Vaccines CDMO Site in China

September 26, 2023

Global Neoantigen Cancer Vaccine Research Report 2023-2031: Regulatory Pathways and Neoantigen Vaccines Navigating the Future of Cancer Immunotherapy

Global Neoantigen Cancer Vaccine Research Report 2023-2031: Regulatory Pathways and Neoantigen Vaccines Navigating the Future of Cancer Immunotherapy

September 25, 2023

Global ATP Assays Market Research Report 2023-2027: Opportunities in Technological Enhancements in ATP Assay Probes & Growth Prospects in Emerging Economies

Global ATP Assays Market Research Report 2023-2027: Opportunities in Technological Enhancements in ATP Assay Probes & Growth Prospects in Emerging Economies

September 25, 2023

Epidemiology of Pancreatic Cancer- Market Access, Statistics, Comprehensive Insights for Stakeholders and Regulatory Guidelines | Disease Landscape Insights

Epidemiology of Pancreatic Cancer- Market Access, Statistics, Comprehensive Insights for Stakeholders and Regulatory Guidelines | Disease Landscape Insights

September 25, 2023

Omixon Launches NanoTYPE MONO™ and MONOall™ RUO, a Singleplex Human Leukocyte Antigen Amplification kit compatible with Oxford Nanopore’s MinION™ Platform

Omixon Launches NanoTYPE MONO™ and MONOall™ RUO, a Singleplex Human Leukocyte Antigen Amplification kit compatible with Oxford Nanopore’s MinION™ Platform

September 25, 2023

MediLink Therapeutics: Focuses on ADC research and development to promote new prospects for cancer treatment

MediLink Therapeutics: Focuses on ADC research and development to promote new prospects for cancer treatment

September 24, 2023

Henlius’ Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC

Henlius’ Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC

September 23, 2023

Smarter Science: How Laboratory Automation Is Shaping the Future of Research and Diagnostics

Smarter Science: How Laboratory Automation Is Shaping the Future of Research and Diagnostics

September 23, 2023

Invitae Receives Notice of Non-Compliance with NYSE Minimum Share Price Continued Listing Standard

Invitae Receives Notice of Non-Compliance with NYSE Minimum Share Price Continued Listing Standard

September 23, 2023

« 1 … 30 31 32 33 34 … 75 »